MaaT Pharma SA (EPA:MAAT)
3.780
+0.090 (2.44%)
Nov 10, 2025, 5:36 PM CET
MaaT Pharma Revenue
MaaT Pharma had revenue of 2.43M EUR in the half year ending June 30, 2025, with 76.12% growth. This brings the company's revenue in the last twelve months to 3.92M, up 52.55% year-over-year. In the year 2024, MaaT Pharma had annual revenue of 3.22M with 44.34% growth.
Revenue (ttm)
3.92M
Revenue Growth
+52.55%
P/S Ratio
15.52
Revenue / Employee
60.34K
Employees
67
Market Cap
60.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.22M | 988.00K | 44.34% |
| Dec 31, 2023 | 2.23M | 798.00K | 55.80% |
| Dec 31, 2022 | 1.43M | 458.00K | 47.12% |
| Dec 31, 2021 | 972.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |